Personal information

Other IDs

Scopus Author ID: 35313274900

Keywords

Adaptive design, Bayesian methods, Statistical methods, Study design and best practice

Activities

Collapse all

Employment (5)

Newcastle University: Newcastle upon Tyne, Newcastle upon Tyne, GB

2017-07-01 to present | Professor of Biostatistics (Institute of Health and Society)
Employment
Source: Self-asserted source
James Wason

Newcastle University: Newcastle upon Tyne, Tyne and Wear, GB

2017-07-01 to present | Professor of Biostatistics (Population Health Sciences)
Employment
Source: check_circle
Newcastle University via ORCID Member Portal

MRC Biostatistics Unit: Cambridge, Cambridgeshire, GB

2015-11-01 to 2020-12-31 | Programme leader-track
Employment
Source: Self-asserted source
James Wason

MRC Biostatistics Unit: Cambridge, Cambridgeshire, GB

2012-04-01 to 2015-10-31 | Senior Investigator Statistician
Employment
Source: Self-asserted source
James Wason

MRC Biostatistics Unit: Cambridge, Cambridgeshire, GB

2009-10-01 to 2012-04-01 | Statistician
Employment
Source: Self-asserted source
James Wason

Education and qualifications (3)

University of Cambridge: Cambridge, GB

2006-10-01 to 2009-10-17 | Ph.D Statistics (MRC Biostatistics Unit)
Education
Source: Self-asserted source
James Wason

University of Cambridge: Cambridge, GB

2005-10-01 to 2006-07-01 | M.Phil Statistical Science (Mathematics)
Education
Source: Self-asserted source
James Wason

University of Cambridge: Cambridge, GB

2002-10-01 to 2005-07-01 | BA Mathematics (Mathematics)
Education
Source: Self-asserted source
James Wason

Funding (33)

optimum therapy for those with Atrial Fibrillation aFtEr Completing miTral valve repair surgery - The AFFECT trial

2024-10-01 to 2030-05-31 | Grant
National Institute for Health and Care Research (London, GB)
URL: https://app.dimensions.ai/details/grant/grant.14087478
GRANT_NUMBER: NIHR160252
Source: Self-asserted source
James Wason via DimensionsWizard

LifeArc Centre for Acceleration of Rare Disease Trials

Source: Self-asserted source
James Wason

LifeArc-Kidney Research UK Centre for Rare Kidney Diseases

Source: Self-asserted source
James Wason

A randomised trial of adjuvant rituximab in young people with Graves' disease

2024-08-01 to 2030-07-31 | Grant
National Institute for Health and Care Research (London, GB)
URL: https://app.dimensions.ai/details/grant/grant.14087476
GRANT_NUMBER: NIHR159329
Source: Self-asserted source
James Wason via DimensionsWizard

A randomised controlled trial of surgery versus no treatment to RESTORE cardiopulmonary function in severe pectus excavatum The RESTORE Trial.

2024-02-01 to 2030-05-31 | Grant
National Institute for Health and Care Research (London, GB)
URL: https://app.dimensions.ai/details/grant/grant.13891571
GRANT_NUMBER: NIHR158749
Source: Self-asserted source
James Wason via DimensionsWizard

[SaFEGen]: A Statistical Framework for efficient Evidence Generation in diagnostics

2024-01-01 to 2026-12-31 | Grant
Engineering and Physical Sciences Research Council (Swindon, GB)
URL: https://app.dimensions.ai/details/grant/grant.13905397
GRANT_NUMBER: EP/X041298/1
Source: Self-asserted source
James Wason via DimensionsWizard

Bayesian Methods for Sample Size Re-estimation

2023-09-30 to 2027-09-29 | Grant
Engineering and Physical Sciences Research Council (Swindon, GB)
URL: https://app.dimensions.ai/details/grant/grant.13876376
GRANT_NUMBER: 2884699
Source: Self-asserted source
James Wason via DimensionsWizard

Using Synthetic Controls to Improve Randomised Control Trials for Rare

2023-09-30 to 2027-09-29 | Grant
Medical Research Council (London, GB)
URL: https://app.dimensions.ai/details/grant/grant.13875888
GRANT_NUMBER: 2884936
Source: Self-asserted source
James Wason via DimensionsWizard

Managing chronic Myalgia Temporomandibular Disorder (M-TMD): a pragmatic randomised controlled trial of Botulinum toxin type A, Lidocaine, and Amitriptyline/Gabapentin, with internal pilot and cost-effectiveness analysis (MiTiGate trial)

2023-09-01 to 2027-08-31 | Grant
National Institute for Health and Care Research (London, GB)
URL: https://app.dimensions.ai/details/grant/grant.13577583
GRANT_NUMBER: NIHR153888
Source: Self-asserted source
James Wason via DimensionsWizard

SarcoSIGHT- A randomised controlled trial of fluorescence guided sarcoma surgery versus standard of care

2023-07-01 to 2028-04-30 | Grant
National Institute for Health and Care Research (London, GB)
URL: https://app.dimensions.ai/details/grant/grant.13891368
GRANT_NUMBER: NIHR134276
Source: Self-asserted source
James Wason via DimensionsWizard

AI-Multiply

2022-09 to 2025-03 | Grant
National Institute for Health and Care Research (Southampton, GB)
Source: Self-asserted source
James Wason

Memory T cells to improve immunity after TCRab/CD19 depleted haploidentical donor stem cell transplantation for inborn errors of immunity

2022-07 to 2027-08 | Grant
Medical Research Council (London, GB)
Source: Self-asserted source
James Wason

Pulmonary Hypertension: intensification and personalisation of combination Rx (PHoenix)

2022-05 to 2025-04 | Grant
Medical Research Council (London, GB)
Source: Self-asserted source
James Wason

Prostate Resection versus Minimally Invasive Surgery Evaluation Trial - PREMISE trial.

2022-04 to 2028-02 | Grant
National Institute for Health and Care Research (Southampton, GB)
Source: Self-asserted source
James Wason

Disease Modifying Therapy in Primary Billary Cholangitis: A New treatment Paradigm

2022-04 to 2026-06 | Grant
National Institute for Health and Care Research (Southampton, GB)
Source: Self-asserted source
James Wason

Transforming treatment of immune-mediated inflammatory diseases through better trials and evaluations

2021-12 to 2026-11 | Grant
National Institute for Health Research (Southampton, GB)
Source: Self-asserted source
James Wason

Extracorporeal Photophoresis in the treatment of Chronic Lung Allograft Dysfunction: a randomised controlled trial (E-CLAD UK)

2021-04 to 2026-01 | Grant
National Institute for Health Research (Southampton, GB)
Source: Self-asserted source
James Wason

Plasma-cell depletion therapy for severe Graves' disease

2021-02-01 to 2024-01-31 | Grant
Medical Research Council (London, GB)
URL: https://app.dimensions.ai/details/grant/grant.9642323
GRANT_NUMBER: MR/V005898/1
Source: Self-asserted source
James Wason via DimensionsWizard

Novel statistical approaches for basket trials in ageing-related diseases

2021-01-28 to 2024-07-27 | Grant
Engineering and Physical Sciences Research Council (Swindon, GB)
URL: https://app.dimensions.ai/details/grant/grant.9657025
GRANT_NUMBER: 2518263
Source: Self-asserted source
James Wason via DimensionsWizard

What is the value of adaptive designs? Estimating expected value of sample information for adaptive trial designs.

2019-12-01 to 2022-12-31 | Grant
Medical Research Council (London, GB)
URL: https://app.dimensions.ai/details/grant/grant.8856328
GRANT_NUMBER: MR/S036709/1
Source: Self-asserted source
James Wason via DimensionsWizard

A comparison of fludrocortisone, midodrine or usual care to treat orthostatic hypotension – a multi-arm multi-stage randomised controlled trial

2019-11 to 2024-10 | Grant
National Institute for Health Research (Southampton, GB)
Source: Self-asserted source
James Wason

Costing Adaptive Trials (CAT): developing best practice for CTUs supporting adaptive trials

2019-10 to 2020-10 | Grant
National Institute for Health Research (Southampton, GB)
Source: Self-asserted source
James Wason

Ocaliva for Cognitive Symptoms in PBC: A Proof of Concept Study

2019-09 to 2022-12 | Grant
Intercept Pharmaceuticals (NY, NY, US)
Source: Self-asserted source
James Wason

Trials Methodology Research Partnership

2019-06 to 2022-05 | Grant
Medical Research Council (London, GB)
Source: Self-asserted source
James Wason

MICA: NURTuRE - changing the landscape of renal medicine to foster a unified approach to stratified medicine

2018-07-15 to 2022-07-14 | Grant
Medical Research Council (London, GB)
URL: https://app.dimensions.ai/details/grant/grant.7747922
GRANT_NUMBER: MR/R013942/1
Source: Self-asserted source
James Wason via DimensionsWizard

A platform clinical trial approach to the management of Mycobacterium abscessus complex

2018 to 2025 | Grant
National Health and Medical Research Council (ACT, ACT, AU)
Source: Self-asserted source
James Wason

Developing efficient perpetual platform trials to study multiple treatments and multiple biomarkers

2017-02-01 to 2020-01-31 | Grant
Medical Research Council (London, GB)
URL: https://app.dimensions.ai/details/grant/grant.6945684
GRANT_NUMBER: MR/N028171/1
Source: Self-asserted source
James Wason via DimensionsWizard

Multiple Interventions for Diabetic Foot Ulcer Treatment (MIDFUT) tria

2017-02 to 2021-12 | Grant
National Institute for Health Research (Southampton, GB)
Source: Self-asserted source
James Wason

Statistical methods for next-generation clinical trials

2016-12-01 to present | Grant
Medical Research Council (London, GB)
URL: https://app.dimensions.ai/details/grant/grant.7611225
GRANT_NUMBER: MC_UU_00002/6
Source: Self-asserted source
James Wason via DimensionsWizard

Mentalization for Offending Adult Males

2016-01 to 2020-10 | Grant
National Institute for Health Research (Southampton, GB)
Source: Self-asserted source
James Wason

Statistical methods for next-generation clinical trials

2015-11-01 to 2016-11-30 | Grant
Medical Research Council (London, GB)
URL: https://app.dimensions.ai/details/grant/grant.4576409
GRANT_NUMBER: MC_UP_1302/4
Source: Self-asserted source
James Wason via DimensionsWizard

Improving the power of phase II oncology trials through the use of continuous tumour measurements

2015-01 to 2017-12 | Grant
Cancer Research UK (London, GB)
URL: https://app.dimensions.ai/details/grant/grant.5138249
GRANT_NUMBER:

CRUK-A18113
Source: Self-asserted source
James Wason
grade
Preferred source (of 2)‎

Designing and analysing multi-arm multi-stage clinical trials with one or more endpoints

2012-08-31 to 2016-06-29 | Grant
Medical Research Council (London, GB)
URL: https://app.dimensions.ai/details/grant/grant.2782324
GRANT_NUMBER: MR/J004979/1
Source: Self-asserted source
James Wason via DimensionsWizard

Peer review (148 reviews for 11 publications/grants)

Review activity for BMC medicine (1)
Review activity for BMJ open. (1)
Review activity for British journal of cancer. (1)
Review activity for Computer methods and programs in biomedicine. (1)
Review activity for Contemporary clinical trials. (3)
Review activity for Nature reviews. (1)
Review activity for Osteoarthritis and cartilage (2)
Review activity for PLoS medicine. (131)
Review activity for Research in Veterinary Science. (2)
Review activity for The Lancet regional health. (1)
Review activity for The Lancet. (4)
How many people are using ORCID?